Background: Minimal trauma hip fracture is a burden for the Australian health care system, and is associated with significant morbidity and mortality. The highest risk of re-fracture is often in the first 12 months following index fracture. Anti-resorptive medications are effective for reducing the risk of re-fracture. However, data from the Australian and New Zealand Hip Fracture Registry suggests that there is minimal improvement in uptake of appropriate medications from the time of discharge to follow up at 30 or 120 days. We are in the process of developing a pathway to enable treatment of patients with low trauma hip fracture during the window of opportunity whilst they are an inpatient in Canterbury Hospital. This study aims to review the characteristics of these patients to further educate the development of this pathway.
Methods: This is a retrospective review of all adult patients presenting to Canterbury Hospital with a minimal trauma hip fracture between January 2018 and December 2019. Data was collected from the electronic medical record.
Results & Conclusions: A total of 156 patients were identified. Results and conclusions will be presented on the day.